首页|EGFR-mutant non-small cell lung cancer patients harboring CDK4 amplification show favorable response to afatinib:Two case reports

EGFR-mutant non-small cell lung cancer patients harboring CDK4 amplification show favorable response to afatinib:Two case reports

扫码查看

Shuting Zhan、Bo Cheng、Xiwen Liu、Jianfu Li、Ge Bai、Qi Cai、Huiting Wang、Yang Xiang、Chunyan Li、Jianxing He、Wenhua Liang

展开 >

Department of Thoracic Surgery and Oncology,The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Health,State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease,Guangzhou,Guangdong 510120,China

National Center for Respiratory Medicine,State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Diseases,Guangzhou Institute of Respira-tory Health &The First Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong 510120,China

Southern Medical University,Guangzhou,Guangdong 510120,China

Department of Respiratory and Critical Care Medicine,The Tenth Affiliated Hospital of Southern Medical University,Dongguan,Guangdong 523108,China

展开 >

China National Science FoundationChina National Science FoundationScience and Technology Planning Project of GuangzhouNational Key Research &Development Program

82022048823731212022060800132022YFC2505100

2024

中华医学杂志(英文版)
中华医学会

中华医学杂志(英文版)

CSTPCD
影响因子:0.838
ISSN:0366-6999
年,卷(期):2024.137(12)